Theravance Biopharma(TBPH) - 2023 Q3 - Earnings Call Transcript

To conclude, on slide 23, I'll provide an update on our potential to earn milestones on global net sales of TRELEGY. GSK delivered another strong quarter of growth with quarterly and year-to-date net sales reaching $675 million and $2 billion respectively, up 22% and 25% when compared to the same period a year ago. To achieve our first $50 million milestone in 2023, TRELEGY would need to re-examine its net sales to reach $2.9 billion for the year, which based on the Q3 results we now believe is unlikely. Ri ...